Related Experiment Videos
[Targetted antibiotic therapy. Acute sore throat: streptococcus A update]
1Service de Pédiatrie, Hôpital Intercommunal, Créteil.
Allergie Et Immunologie
|November 1, 1994
Summary
Acute sore throat caused by beta-hemolytic Streptococcus A can lead to severe complications like rheumatic fever and septicemia. Early antibiotic treatment with penicillin V is recommended for bacterial pharyngitis to prevent these serious health issues.
Area of Science:
- Infectious Diseases
- Immunology
- Microbiology
Context:
- Acute sore throat is a common condition with potentially severe bacterial causes.
- Beta-hemolytic Streptococcus A (Strep A) is a primary bacterial etiology of pharyngitis.
- Strep A infections are associated with serious distant inflammatory complications and invasive syndromes.
Purpose:
- To highlight the significant, often underestimated, complications of Strep A pharyngitis.
- To explain the immunological mechanisms, including superantigens, involved in severe Strep A infections.
- To advocate for targeted antibiotic therapy for bacterial sore throat.
Summary:
- Beta-hemolytic Streptococcus A can cause severe health issues beyond sore throat, including acute rheumatic fever, glomerulonephritis, invasive fasciitis, and life-threatening septicemia.
- Understanding the role of bacterial superantigens in immune response is crucial for defining disease pathogenesis.
- Rapid diagnostic tests for Strep A are available but not widely accessible, underscoring the need for clinical judgment and targeted treatment.
Impact:
- Emphasizes the importance of recognizing Strep A as a significant pathogen, not just a cause of common sore throat.
- Supports the use of penicillin V as a first-line antibiotic for Strep A pharyngitis due to its efficacy and low resistance risk.
- Highlights the need for improved access to rapid diagnostic tools and appropriate antibiotic stewardship in managing bacterial pharyngitis.